It targets the CD20 antigen over the floor of B cells (cancerous white blood cells) and CD3 on the surface of T cells (a white blood cell that helps to shield you from illness.Acceptance: In the event the NDA satisfies the necessary requirements, the FDA will approve the drug. Otherwise, the applying might be rejected or the developer might need to